Caroline P Martens

Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19

M. Vanhove, P. Verhamme, J. Neyts, 2022, eBioMedicine.

Neutrophils Protect Against Staphylococcus aureus Endocarditis Progression Independent of Extracellular Trap Release

D. Missiakas, P. Verhamme, P. Baatsen, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study

G. Van den Berghe, C. Wouters, P. Verhamme, 2022, Research and Practice in Thrombosis and Haemostasis.

Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing

P. Verhamme, S. Janssens, B. Vandenberk, 2022, Research and Practice in Thrombosis and Haemostasis.

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

F. Comte, M. Prins, L. Morssink, 2022, The Lancet.